Alexander Mark Schobel, Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc. (AQST), sold 35,000 shares at $6.75 ($236K) on 2021-02-09, disclosed to the SEC on 2021-02-10.
Open-market sale of $236k AQST by Chief Innovation/Tech Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.75 | 11,540 | $78K | 33.0% |
| 2 | $6.75 | 23,460 | $158K | 67.0% |
| Total | $6.75 avg | 35,000 | $236K | 100% |
| Filing → |
| AQST | BUY | 2022-06-10 | $44K | — | Filing → |
| AQST | SELL | 2021-02-09 | $265K | — | Filing → |
| AQST | SELL | 2020-05-11 | $200K | — | Filing → |